• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Bay Area BioEconomy Initiative appoints Pablo Cagnoni to steering committee

Bay Area BioEconomy Initiative appoints Pablo Cagnoni to steering committee

September 12, 2014
CenterWatch Staff

The Bay Area BioEconomy Initiative (BAB) has named Pablo J. Cagnoni, M.D., president of Onyx Pharmaceuticals, to its steering committee. Onyx, an Amgen subsidiary, is engaged in the development and commercialization of innovative therapies to improve the lives of people with cancer.

The Bay Area BioEconomy Initiative, which brings together the biotech industry, universities, investors, medical centers, health insurers, the technology sector and government, has established three strategic imperatives to improve human health: increasing efficiency in clinical trials; accelerating the timeline of drug discovery, development and diagnosis in areas of significant unmet medical need; and expediting the implementation of innovative technological advances into the everyday practice of medicine.

The Bay Area BioEconomy Initiative steering committee represents members, Bay Area institutions and companies and other stakeholders when making major decisions for the initiative. It is responsible for creating and implementing policies, activities and events that foster innovation and collaboration to strengthen the Bay Area BioEconomy. The steering committee also represents Bay Area BioEconomy Initiative to the community.

Cagnoni currently is president of Onyx Pharmaceuticals, where he has global accountability for product development and commercial strategy for the Onyx portfolio. He joined Onyx in March 2013 as executive vice president, global R&D and technical operations and was named president in October 2013, when Onyx became a subsidiary of Amgen.

Cagnoni previously was senior vice president and global head of clinical development at Novartis Oncology, senior vice president and chief medical officer at Allos Therapeutics and, prior to that, was chief medical officer of OSI Pharmaceuticals.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing